Articles
-
Latinos Are More Likely to Die From COVID-19, Underlining Racial and Ethnic Disparities in Outcomes
Latinos were tested more for COVID-19 and had higher rates of infection, hospitalization and death.
Categorized in -
Risk of Losing Cash Reward Strongly Impacts Exercise Habit
Researchers found adults were incentivized to exercise more often for the same anticipated cash reward simply by changing how the reward is delivered.
Categorized in -
Mandatory Masking of School Children is a Bad Idea
The benefits of masks in preventing serious illness or death from COVID-19 among children are small. Meanwhile, they are disruptive to learning and communicating in classrooms.
Categorized in -
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Categorized in -
A Medical Moonshot Would Help Fix Inequality in American Healthcare
New medical interventions can serve as a great leveler and help change the trajectory of health disparities in the United States.
Categorized in -
Experts at Schaeffer-Aspen Webinar Discuss Modernizing Health Technology Assessment in the U.S.
The U.S. does not have a coordinated process to evaluate the effectiveness and value of new devices, medicines or procedures. Schaeffer Center and the Aspen Institute hosted a panel discussion on the viability of an Institute of Health Technology Assessment.
-
Congress Ends Surprise Billing Implications for Payers, Providers and Patients
The No Surprises Act represents a rare bipartisan moment for Congress and a long-needed safeguard for patients that will reorient relationships among payers and providers.
Categorized in -
Precision Medicine: Moving Theory into Practice
Over a four-part webinar series, Schaeffer Center will bring together experts to discuss how we can move precision medicine from theory to practice.
-
FDA’s Approval of Aducanumab Paves the Way for ‘More Momentous’ Alzheimer’s Breakthroughs
The FDA’s recent approval of the first disease-modifying therapy for Alzheimer’s will fuel the chances of even more breakthroughs.
-
USC Study Finds When Medicare Chips in for Hepatitis C Treatment for Medicaid Patients, Everyone Wins
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years
Categorized in